| Patent | Date |
|---|
Methods And Compositions For Tusc2 Immunotherapy
App 20220168388 - ROTH; Jack A. ; et al. | 2022-06-02 |
Methods and compositions for TUSC2 immunotherapy
Grant 11,278,592 - Roth , et al. March 22, 2 | 2022-03-22 |
Cationic Liquid Crystalline Nanoparticles
App 20200197306 - GENTILE; Emanuela ; et al. | 2020-06-25 |
Methods And Compositions For Tusc2 Immunotherapy
App 20200038480 - ROTH; Jack A. ; et al. | 2020-02-06 |
Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases
Grant 10,293,056 - Ramesh , et al. | 2019-05-21 |
Bioactive FUS1 peptides and nanoparticle-polypeptide complexes
Grant 8,859,727 - Lin , et al. October 14, 2 | 2014-10-14 |
hTMC promoter and vectors for the tumor-selective and high-efficient expression of cancer therapeutic genes
Grant 8,658,778 - Ji , et al. February 25, 2 | 2014-02-25 |
Bioactive Fus1 Peptides And Nanoparticle-polypeptide Complexes
App 20130266634 - LIN; Jacki ; et al. | 2013-10-10 |
Bioactive FUS1 peptides and nanoparticle-polypeptide complexes
Grant 8,338,366 - Lin , et al. December 25, 2 | 2012-12-25 |
Tusc2 Therapies
App 20120244209 - Roth; Jack A. ; et al. | 2012-09-27 |
Antihelminthic drugs as a treatment for hyperproliferative diseases
Grant 7,423,015 - Mukhopadhyay , et al. September 9, 2 | 2008-09-09 |
Recombinant p53 adenovirus methods and compositions
App 20070190040 - Zhang; Wei-Wei ; et al. | 2007-08-16 |
Diminishing viral gene expression by promoter replacement
Grant 7,244,617 - Fang , et al. July 17, 2 | 2007-07-17 |
Novel hTMC promoter and vectors for the tumor-selective and high-efficient expression of cancer therapeutic genes
App 20070092968 - Ji; Lin X. ; et al. | 2007-04-26 |
p16 expression constructs and their application in cancer therapy
Grant 7,163,925 - Jin , et al. January 16, 2 | 2007-01-16 |
Bioactive FUS1 peptides and nanoparticle-polypeptide complexes
App 20060251726 - Lin; Jacki ; et al. | 2006-11-09 |
Methods and compositions comprising DNA damaging agents and p53
Grant 7,109,179 - Roth , et al. September 19, 2 | 2006-09-19 |
Methods and compositions comprising DNA damaging agents and p53
App 20060182718 - Roth; Jack A. ; et al. | 2006-08-17 |
Recombinant P53 adenovirus methods and compositions
Grant 7,033,750 - Zhang , et al. April 25, 2 | 2006-04-25 |
Combination treatment of cancer with elicitor of gene product expression and gene-product targeting agent
App 20060052322 - Roth; Jack A. ; et al. | 2006-03-09 |
Cancer treatment with retroviral vectors comprising wild-type p53
Grant 6,998,117 - Roth , et al. February 14, 2 | 2006-02-14 |
Induction of apoptic or cytotoxic gene expression by adenoviral mediated gene codelivery
App 20060002895 - McDonnell; Timothy J. ; et al. | 2006-01-05 |
Methods and compositions for improved non-viral gene therapy
App 20050143336 - Ramesh, Rajagopal ; et al. | 2005-06-30 |
Recombinant p53 adenovirus methods and compositions
Grant 6,905,873 - Zhang , et al. June 14, 2 | 2005-06-14 |
Induction of apoptic or cytotoxic gene expression by adenoviral mediated gene codelivery
Grant 6,899,870 - McDonnell , et al. May 31, 2 | 2005-05-31 |
Methods and compositions comprising DNA damaging agents and p53
App 20050089511 - Roth, Jack A. ; et al. | 2005-04-28 |
Diminishing viral gene expression by promoter replacement
App 20050026139 - Fang, Bingliang ; et al. | 2005-02-03 |
Recombinant P53 adenovirus methods and compositions
Grant 6,830,749 - Zhang , et al. December 14, 2 | 2004-12-14 |
Methods for the administration of adenovirus p53
Grant 6,805,858 - Zhang , et al. October 19, 2 | 2004-10-19 |
Methods and compositions comprising DNA damaging agents and P53
Grant 6,797,702 - Roth , et al. September 28, 2 | 2004-09-28 |
Recombinant P53 adenovirus methods and compositions
Grant 6,740,320 - Zhang , et al. May 25, 2 | 2004-05-25 |
Diminishing viral gene expression by promoter replacement
Grant 6,630,344 - Fang , et al. October 7, 2 | 2003-10-07 |
Inhibition of cellular proliferation using ras antisense molecules
Grant 6,627,189 - Roth , et al. September 30, 2 | 2003-09-30 |
2-Methoxyestradiol-induced apoptosis in cancer cells
App 20030099614 - Mukhopadhyay, Tapas ; et al. | 2003-05-29 |
Adenovirus P53 Compositions And Methods
App 20030039631 - ROTH, JACK A. | 2003-02-27 |
Recombinant p53 adenovirus methods and compositions
App 20030021767 - Zhang, Wei-Wei ; et al. | 2003-01-30 |
Recombinant p53 adenovirus methods and compositions
App 20030012770 - Zhang, Wei-Wei ; et al. | 2003-01-16 |
Modification of mutated P53 gene in tumors by retroviral delivery of ribozyme A
Grant 6,482,803 - Roth , et al. November 19, 2 | 2002-11-19 |
2-methoxyestradiol-induced apoptosis in cancer cells
Grant 6,410,029 - Mukhopadhyay , et al. June 25, 2 | 2002-06-25 |
P16 expression constructs and their application in cancer therapy
Grant 6,251,871 - Jin , et al. June 26, 2 | 2001-06-26 |
Tumor regression by adenovirus expression of wild-type p53
Grant 6,143,290 - Zhang , et al. November 7, 2 | 2000-11-07 |
Diminishing viral gene expression by promoter replacement
Grant 6,110,744 - Fang , et al. August 29, 2 | 2000-08-29 |
Methods and compositions comprising DNA damaging agents and p53
Grant 6,069,134 - Roth , et al. May 30, 2 | 2000-05-30 |
Inhibiting the growth p53 deficient tumor cells by administering the p53 gene
Grant 6,017,524 - Roth , et al. January 25, 2 | 2000-01-25 |
2-methoxyestradiol-induced apoptosis in cancer cells
Grant 5,958,892 - Mukhopadhyay , et al. September 28, 1 | 1999-09-28 |
Methods and compositions comprising DNA damaging agents and p53
Grant 5,747,469 - Roth , et al. May 5, 1 | 1998-05-05 |
Rapid test for determining the amount of functionally inactive gene in a gene therapy vector preparation
Grant 5,637,456 - Roth , et al. June 10, 1 | 1997-06-10 |
| 